4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000005
Director sold 13,500 shares at an average $90.06 ($1,215,853)
- Director acquired 13,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Golumbeski George · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-11 | Exercise or conversion : show line 1 in the form | +2,272 | $25.58 | $58,118 | 2,272 | D |
| 2019-02-11 | Sale : show line 2 in the form | −2,272 | $90.03 | $204,552 | 0 | D |
| 2019-02-12 | Exercise or conversion : show line 3 in the form | +3,728 | $25.58 | $95,362 | 3,728 | D |
| 2019-02-12 | Exercise or conversion : show line 4 in the form | +7,500 | $29.02 | $217,650 | 11,228 | D |
| 2019-02-12 | Sale : show line 5 in the form | −11,228 | $90.07 | $1,011,301 | 0 | D |
| Open-market sales · 13,500 sh · avg $90.06 · $1,215,853 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-02-11 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −2,272 | $25.58 | 2026-02-11 | 2,272 | 3,728 | D |
| 2019-02-12 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,728 | $25.58 | 2026-02-11 | 3,728 | 0 | D |
| 2019-02-12 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −7,500 | $29.02 | 2027-02-16 | 7,500 | 0 | D |
Loading xslF345X03/edgar.xml…